Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial

Bengt I. Eriksson, Ola E. Dahl, Michael H. Huo, Andreas A. Kurth, Stefan Hantel, Karin Hermansson, Janet M. Schnee, Richard J. Friedman

Research output: Contribution to journalArticlepeer-review

338 Scopus citations

Fingerprint

Dive into the research topics of 'Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II): A randomised, double-blind, non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences